{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:16:27Z","timestamp":1777886187923,"version":"3.51.4"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100006049","name":"Comisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica","doi-asserted-by":"publisher","award":["2015-56"],"award-info":[{"award-number":["2015-56"]}],"id":[{"id":"10.13039\/501100006049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024018","name":"Programa de Desarrollo de las Ciencias B\u00e1sicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008725","name":"Agencia Nacional de Investigaci\u00f3n e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["ANII- FMV_3_2016_1_125748"],"award-info":[{"award-number":["ANII- FMV_3_2016_1_125748"]}],"id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.biologicals.2023.101737","type":"journal-article","created":{"date-parts":[[2023,12,14]],"date-time":"2023-12-14T01:43:07Z","timestamp":1702518187000},"page":"101737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis"],"prefix":"10.1016","volume":"85","author":[{"given":"Cecilia","family":"Silvarrey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Alvite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4804-1800","authenticated-orcid":false,"given":"Adriana","family":"Esteves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2023.101737_bib1","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1128\/JCM.02420-15","volume":"54","author":"Agudelo Higuita","year":"2016","journal-title":"CysticEchinococcosis. J Clin Microbiol."},{"issue":"Suppl","key":"10.1016\/j.biologicals.2023.101737_bib2","doi-asserted-by":"crossref","first-page":"S181","DOI":"10.1016\/j.parint.2005.11.048","article-title":"Cystic echinococcosis in America","volume":"55","author":"Moro","year":"2006","journal-title":"Parasitol Int"},{"issue":"Suppl","key":"10.1016\/j.biologicals.2023.101737_bib3","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1016\/j.parint.2005.11.028","article-title":"The present situation of echinococcosis in Europe","volume":"55","author":"Romig","year":"2006","journal-title":"Parasitol Int"},{"issue":"Suppl","key":"10.1016\/j.biologicals.2023.101737_bib4","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.parint.2005.11.029","article-title":"Epidemiology and control of echinococcosis in sub-Saharan Africa","volume":"55","author":"Magambo","year":"2006","journal-title":"Parasitol Int"},{"issue":"12","key":"10.1016\/j.biologicals.2023.101737_bib5","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.ijpara.2014.07.005","article-title":"Echinococcus as a model system: biology and epidemiology","volume":"44","author":"Thompson","year":"2014","journal-title":"Int J Parasitol"},{"issue":"4","key":"10.1016\/j.biologicals.2023.101737_bib6","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1590\/S1726-46342010000400017","article-title":"Southern cone sub-regional project on cystic echinococcosis control and surveillance","volume":"27","author":"Irabedra","year":"2010","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"key":"10.1016\/j.biologicals.2023.101737_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1590\/S1020-49892012000100012","article-title":"Critical analysis of cystic echinococcosis control programs and praziquantel use in South America, 1974-2010","volume":"31","author":"Larrieu","year":"2012","journal-title":"RevPanam Salud P\u00fablica"},{"key":"10.1016\/j.biologicals.2023.101737_bib8","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4067\/S0717-77122004000100018","article-title":"Echinococcosis qu\u00edstica: epidemiolog\u00eda y control en Am\u00e9rica del Sur","volume":"59","author":"Larrieu","year":"2004","journal-title":"Parasitol Latinoam"},{"issue":"Suppl","key":"10.1016\/j.biologicals.2023.101737_bib9","doi-asserted-by":"crossref","first-page":"S143","DOI":"10.1017\/S0031182003003810","article-title":"Transmission dynamics and control options for Echinococcus granulosus","volume":"127","author":"Torgerson","year":"2003","journal-title":"Parasitology"},{"key":"10.1016\/j.biologicals.2023.101737_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3024.1996.tb01029.x","article-title":"Vaccination against hydatidosis using a defined recombinant antigen","volume":"18","author":"Lightowlers","year":"1996","journal-title":"Parasite Immunol"},{"issue":"2","key":"10.1016\/j.biologicals.2023.101737_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.actatropica.2013.04.009","article-title":"Pilot field trial of the EG95 vaccine against ovine cystic echinococcosis in Rio Negro, Argentina: early impact and preliminary data","volume":"127","author":"Larrieu","year":"2013","journal-title":"Acta Trop"},{"key":"10.1016\/j.biologicals.2023.101737_bib12","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"Reactive FuntionalPoym"},{"key":"10.1016\/j.biologicals.2023.101737_bib13","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1080\/21645515.2015.1063756","article-title":"Novel nanoparticle vaccines for Listeriosis","volume":"11","author":"Calderon-Gonzalez","year":"2015","journal-title":"Hum Vaccines Immunother"},{"issue":"2","key":"10.1016\/j.biologicals.2023.101737_bib14","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031472","article-title":"Antigen-displaying lipid-enveloped PLGA nanoparticles as delivery agents for a Plasmodium vivax malaria vaccine","volume":"7","author":"Moon","year":"2012","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.biologicals.2023.101737_bib15","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.vaccine.2015.02.016","article-title":"A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice","volume":"33","author":"Hunsawong","year":"2015","journal-title":"Vacccine"},{"key":"10.1016\/j.biologicals.2023.101737_bib16","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2016.06.018","article-title":"Polylactic acid (PLA) controlled delivery carriers for biomedical applications","volume":"107","author":"Tyler","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.biologicals.2023.101737_bib17","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.biomaterials.2008.10.035","article-title":"The enhancement of the immune response against S. equi antigens through the intranasal administration of poly-epsilon-caprolactone-based nanoparticles","volume":"30","author":"Florindo","year":"2009","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.biologicals.2023.101737_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022889","article-title":"RD antigen based nanovaccine imparts long term protection by inducing memory response against experimental murine tuberculosis","volume":"6","author":"Ansari","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.biologicals.2023.101737_bib19","doi-asserted-by":"crossref","first-page":"9026","DOI":"10.1016\/j.vaccine.2011.09.033","article-title":"Development and characterization of chitosan coated poly-(\u025b-caprolactone) nanoparticulate system for effective immunization against influenza","volume":"29","author":"Gupta","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101737_bib20","doi-asserted-by":"crossref","first-page":"4953","DOI":"10.1016\/j.vaccine.2011.04.112","article-title":"Pharmaceutical and immunological evaluation of mucoadhesive nanoparticles based delivery system(s) administered intranasally","volume":"29","author":"Mangal","year":"2011","journal-title":"Vaccine"},{"issue":"48","key":"10.1016\/j.biologicals.2023.101737_bib21","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1016\/j.vaccine.2011.09.070","article-title":"Blood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodies","volume":"29","author":"Pusic","year":"2011","journal-title":"Vaccine"},{"issue":"33","key":"10.1016\/j.biologicals.2023.101737_bib22","doi-asserted-by":"crossref","first-page":"4983","DOI":"10.1016\/j.vaccine.2012.05.033","article-title":"Low efficacy of NcGRA7, NcSAG4, NcBSR4 and NcSRS9 formulated in poly-\u03b5-caprolactone against Neospora caninum infection in mice","volume":"30","author":"Jim\u00e9nez-Ruiz","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101737_bib23","article-title":"Oral vaccination based on DNA-chitosan nanoparticles against Schistosoma mansoni infection","volume":"938457","author":"Oliveira","year":"2012","journal-title":"Sci World J"},{"key":"10.1016\/j.biologicals.2023.101737_bib24","first-page":"2115","article-title":"Towards development of novel immunization strategies against leishmaniasis using PLGA nanoparticles loaded with kinetoplastid membrane protein-11","volume":"7","author":"Santos","year":"2012","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.biologicals.2023.101737_bib25","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/23\/32\/325101","article-title":"Biodegradable PLGA 85\/15 nanoparticles as a delivery vehicle for Chlamydia trachomatis recombinant MOMP-187 peptide","volume":"23","author":"Taha","year":"2012","journal-title":"Nanotechnology"},{"issue":"5","key":"10.1016\/j.biologicals.2023.101737_bib26","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.tube.2011.01.003","volume":"91","author":"Tyagi","year":"2011","journal-title":"Dev vaccines tuberculosis. Tuberculosis (Edinb)"},{"key":"10.1016\/j.biologicals.2023.101737_bib27","doi-asserted-by":"crossref","first-page":"8447","DOI":"10.1016\/S0021-9258(18)92995-9","article-title":"A 14-kDa Schistosoma mansoni polypeptide is homologous to a gene family of fatty acid binding proteins","volume":"266","author":"Moser","year":"1991","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biologicals.2023.101737_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/0014-4894(92)90202-L","article-title":"Fasciola hepatica: molecular cloning, nucleotide sequence, and expression of a gene encoding a polypeptide homologous to a Schistosoma mansoni fatty acid-binding protein","volume":"74","author":"Rodr\u00edguez-P\u00e9rez","year":"1992","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.biologicals.2023.101737_bib29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1079\/JOH2005304","article-title":"Fasciola antigens as vaccines against fascioliasis and schistosomiasis","volume":"79","author":"Hillyer","year":"2005","journal-title":"J Helminthol"},{"key":"10.1016\/j.biologicals.2023.101737_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.actatropica.2008.03.003","article-title":"Peptides containing T cell epitopes, derived from Sm14, but not from paramyosin, induce a Th1 type of immune response, reduction in liver pathology and partial protection against Schistosoma mansoni infection in mice","volume":"106","author":"Garcia","year":"2008","journal-title":"Acta Trop"},{"issue":"2\u20133","key":"10.1016\/j.biologicals.2023.101737_bib31","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.actatropica.2008.09.002","article-title":"The biotechnology-value chain: development of Sm14 as a schistosomiasis vaccine","volume":"108","author":"Tendler","year":"2008","journal-title":"Acta Trop"},{"issue":"1","key":"10.1016\/j.biologicals.2023.101737_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13567-021-00895-0","article-title":"Efficacy of a multivalent vaccine against Fasciola hepatica infection in sheep","volume":"52","author":"Zafra","year":"2021","journal-title":"Vet Res"},{"key":"10.1016\/j.biologicals.2023.101737_bib33","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.bbapap.2008.12.010","article-title":"Stability improvement of the fatty acid binding protein Sm14 from S. mansoni by Cys replacement: structural and functional characterization of a vaccine candidate","volume":"1794","author":"Ramos","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.biologicals.2023.101737_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.vetpar.2011.09.027","article-title":"Humoral immune response in goats immunised with cathepsin L1, peroxiredoxin and Sm14 antigen and experimentally challenged with Fasciola hepatica","volume":"185","author":"Buffoni","year":"2012","journal-title":"Vet Parasitol"},{"issue":"4","key":"10.1016\/j.biologicals.2023.101737_bib35","first-page":"121","article-title":"Current status of the Sm14\/GLA-SE schistosomiasis vaccine: overcoming barriers and paradigms towards the first anti-parasitic human (itarian) vaccine","volume":"3","author":"Tendler","year":"2018","journal-title":"Trav Med Infect Dis"},{"key":"10.1016\/j.biologicals.2023.101737_bib36","doi-asserted-by":"crossref","unstructured":"Bilati U, Allemann E, Doelker E. Nanoprecipitation versus emulsion-based techniques for the encapsulation of proteins into biodegradable nanoparticles and process-related stability issues. AAPS PharmSciTech. 2005b Dec 1;6(4). https:\/\/doi:10.1208\/pt060474.","DOI":"10.1208\/pt060474"},{"issue":"3","key":"10.1016\/j.biologicals.2023.101737_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ejpb.2005.03.002","article-title":"Simulation of fasting gastric conditions and its importance for the in vivo dissolution of lipophilic compounds","volume":"60","author":"Vertzoni","year":"2005","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.biologicals.2023.101737_bib38","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1023\/A:1011910801212","article-title":"Evaluation of various dissolution media for predicting in vivo performance of class I and II drugs","volume":"15","author":"Galia","year":"1998","journal-title":"Pharm Res (N Y)"},{"key":"10.1016\/j.biologicals.2023.101737_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.vetpar.2022.109790","article-title":"Analysis of vaccination strategy against cystic echinococcosis developed in the Province of R\u00edo Negro, Argentina: 12 years of work","volume":"310","author":"Labanchi","year":"2022","journal-title":"Vet Parasitol"},{"issue":"9","key":"10.1016\/j.biologicals.2023.101737_bib40","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.pt.2008.05.008","article-title":"Vaccination of dogs against Echinococcus granulosus: a means to control hydatid disease?","volume":"24","author":"Zhang","year":"2008","journal-title":"Trends Parasitol"},{"issue":"14","key":"10.1016\/j.biologicals.2023.101737_bib41","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/j.vaccine.2015.02.016","article-title":"A novel dengue virus serotype-2 nanovaccine induces robust humoral and cell-mediated immunity in mice","volume":"33","author":"Hunsawong","year":"2015","journal-title":"Vacccine"},{"key":"10.1016\/j.biologicals.2023.101737_bib42","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2007.09.013","article-title":"Nano\/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives","volume":"125","author":"Mundargi","year":"2008","journal-title":"J Contr Release: Off J Control Release Soc"},{"key":"10.1016\/j.biologicals.2023.101737_bib43","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijpharm.2009.10.018","article-title":"Polymer-based nanocapsules for drug delivery","volume":"385","author":"Mora-HuertasC","year":"2010","journal-title":"Int J Pharm"},{"key":"10.1016\/j.biologicals.2023.101737_bib44","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.biologicals.2021.01.003","article-title":"Development and evaluation of polymeric nanoparticles as a delivery system for snake envenoming prevention","volume":"70","author":"Hamzaoui","year":"2001","journal-title":"Biologicals"},{"issue":"1","key":"10.1016\/j.biologicals.2023.101737_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oraldelivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J Contr Release"},{"key":"10.1016\/j.biologicals.2023.101737_bib46","series-title":"Polymers in nanomedicine","article-title":"Biodegradable nanoparticles as vaccine adjuvants and delivery systems: regulation of immune responses by nanoparticle-based vaccine","volume":"vol. 247","author":"Akagi","year":"2011"},{"key":"10.1016\/j.biologicals.2023.101737_bib47","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1073\/pnas.0804897106","article-title":"Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome","volume":"106","author":"Sharp","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biologicals.2023.101737_bib48","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1016\/j.vaccine.2003.12.032","article-title":"Characterization of poly (D,L-lactic-co-glycolic acid)-based nanoparticulate system for enhanced delivery of antigens to dendritic cells","volume":"22","author":"Elamanchili","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2023.101737_bib49","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.ijpharm.2009.05.069","article-title":"The gastrointestinal stability of lipid nanocapsules","volume":"379","author":"Roger","year":"2009","journal-title":"Int J Pharm"},{"issue":"3","key":"10.1016\/j.biologicals.2023.101737_bib50","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.bbagen.2013.12.014","article-title":"Physicochemical properties and in vitro intestinal permeability properties and intestinal cell toxicity of silica particles, performed in simulated gastrointestinal fluids","volume":"1840","author":"Sakai-Kato","year":"2014","journal-title":"Biochim Biophys Acta"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105623000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105623000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T03:29:08Z","timestamp":1777606148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105623000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":50,"alternative-id":["S1045105623000763"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2023.101737","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanoparticle formulation for the development of a dog nanovaccine against Cystic Echinococcosis","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2023.101737","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101737"}}